About this podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
396 episodes · science
BioCentury This Week
About this podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Latest episodeEp. 386 - Novartis misses, pharma deals analysis, MFN carve-outs
Recent episodes
- Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton1 Sept · 36 min
- Ep. 384 - Back to School Special: The global FIH trials race28 Aug · 43 min
- Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick25 Aug · 19 min
- Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA18 Aug · 25 min
- Ep. 381 - FIH urgency in the U.S. Plus: federated learning, biotech IPOs11 Aug · 32 min
- Ep. 380 - AZ-BMS rumors, Replimune, psychedelics4 Aug · 32 min
- Ep. 379 - Argenx M&A, AI giants and biopharma, catalyst scorecard28 Jul · 34 min
- Ep. 378 - U.K. cabinet shuffle, Taiwan biotech and Biogen data21 Jul · 42 min
- Ep. 377 - Trends in life sciences talent with CBRE's Ian Anderson15 Jul · 29 min
- Ep. 376 - M&A momentum: 3Q public markets preview14 Jul · 33 min
podlinkr.com/en/biocentury-this-week
For a poster or slide.